Brain acetylcholinesterase activity in mild cognitive impairment and early Alzheimer's disease

Journal of Neurology Neurosurgery and Psychiatry

Volumn 74, Issue 1, 2003, Pages 113-115

  Rinne, Juha O ^a,b   Kaasinen, V ^a   Jarvenpaa T ^b   Nagren K ^b   Roivainen, A ^b   Yu, M ^b   Oikonen, V ^b   Kurki, T ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU PET CENTRE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; METHYL N METHYLPIPERIDYL 4 ACETATE C 11; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; HIPPOCAMPUS; HUMAN; MALE; MINI MENTAL STATE EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; THREE DIMENSIONAL IMAGING;

ACETATES; ACETYLCHOLINESTERASE; AGED; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; BRAIN; CARBON RADIOISOTOPES; COGNITION DISORDERS; FEMALE; HIPPOCAMPUS; HUMANS; IMAGING, THREE-DIMENSIONAL; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PIPERIDINES; PREDICTIVE VALUE OF TESTS; REFERENCE VALUES; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0037224741     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.74.1.113     Document Type: Article

References (21)

1. Perry EK, Perry RH, Blessed G, et al. Necropsy evidence of central cholinergic deficits in senile dementia. Lancet 1977;i:189.
2. Francis PT, Palmer AM, Snape M, et al. The cholinergic hypothesis of Alzheimer's disease: A review of progress. J Neurol Neurosurg Psychiatry 1999;66:137-47.
3. Kuhl DE, Koeppe RA, Minoshima S, et al. In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease. Neurology 1999;52:691-9.
4. Iyo M, Namba H, Fukushi K, et al. Measurement of acetylcholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimer's disease. Lancet 1997;349:1805-9.
5. Shinotoh H, Aotsuka A, Fukushi K, et al. Effect of donepezil on brain acetylcholinesterase activity in patients with AD measured with PET. Neurology 2001;56:408-10.
6. Shinotoh H, Namba H, Fukushi K, et al. Progressive loss of cortical acetylcholinesterase activity in association with cognitive decline in Alzheimer's disease: A positron emission tomography study. Ann Neurol 2000;48:194-200.
7. Herholz K, Bauer B, Wienhard K, et al. In-vivo measurement of regional acetylcholine esterase activity in degenerative dementia: Comparison with blood flow and glucose metabolism. J Neural Tronsm 2000;107:1457-68.
8. Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment: Clinical characterization and outcome. Arch Neurol 1999;56:303-8.
9. Petersen RC, Stevens JC, Ganguli M, et al. Practice parameter: Early detection of dementia: Mild cognitive impairment (an evidence based review). Neurology 2001;56:1133-42.
10. Du AT, Schuff N, Amend D, et al. Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease. J Neurol Neurosurg Psychiatry 2001;71:441-7.
11. Kordower JH, Chu Y, Stebbins GT, et al. Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment. Ann Neurol 2001;49:202-13.
12. De Santi S, de Leon MJ, Rusinek H, et al. Hippocampal formation glucose metabolism and volume losses in MCI and AD. Neurobiol Aging 2001;22:529-39.
13. Kaasinen V, Någren K, Järvenpää T, et al. Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer's disease. J Clin Psychopharmacol (in press).
14. Pellizzari CA, Chen GTY, Spelbring DR, et al. Accurate three-dimensional registration of CT, PET, and/or MR images of the brain. J Comput Assist Tomogr 1989;13:20-6.
15. Namba H, Iyo M, Fukushi K, et al. Human cerebral acetylcholinesterase activity measured with positron emission tomography: Procedure, normal values and effect of age. Eur J Nucl Med 1999;26:135-43.
16. Scheltens P, Leys D, Barkhof F, et al. Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: Diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 1992;55:967-72.
17. Davis KL, Mohs RC, Marin D, et al. Cholinergic markers in elderly patients with early signs of Alzheimer's disease. JAMA 1999;281;1401-6.
18. DeKosky ST, Ikonomovic MD, Styren SD, et al. Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann Neurol 2001;51:145-55.
19. Gilmor ML, Erickson JD, Varoqui H, et al. Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease. J Comp Neurol 1999;411:693-704.
20. Wahlund LO, Julin P, Johansson SE, et al. Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia: A comparative study. J Neurol Neurosurg Psychiatry 2000;69:630-5.
21. Mesulam M. Neuroanatomy of cholinesterases in the normal human brain and in Alzheimer's disease. In: Giacobini E, ed. Cholinesterases and Cholinesterase Inhibitors. London: Martin Dunitz, 2000:121-37.